Level 4: Emotional Healing

 

A diagnosis of cancer is usually an unexpected and deeply unsettling experience. For most individuals, nothing is, or ever will be, the same again. Historically, the intense emotions arising with a cancer crisis are regarded by the mainstream health care system as being of secondary importance to the disease itself. Emotional pain or distress is seen as a common but unfortunate and inconvenient problem to be “managed,” often with medications, and with the least amount of self-inquiry or introspection possible. Such an approach is profoundly short sighted and can be very damaging. By minimizing the importance of healing on an emotional level, opportunities for profound awakening and transformation are often missed. It can also have a variety of adverse affects on significant aspects of the treatment course and on one’s general health. It may ultimately influence survival as well.

Level 4 marks an important turning point in The Seven Levels of Healing® program. Here, the general focus and attention of patients and family members is gently redirected from the “outer” world of science, medicine, and complementary and alternative medicine (CAM) therapies into the “inner” world of feelings and personal emotional experience. The focus shifts from drugs, pills, surgery, support groups, diets, exercise, and other external activities to realms of deep inner awareness and the heart. For many people, this transition may not be easy because of the different kinds of emotions that might be encountered along the way, including fear, pain, anger, sadness, grief, and turmoil. Nonetheless, safely working through and releasing these feelings is an essential component of a “whole person” approach to care.

Addressing the myriad emotional issues encountered on the journey through cancer requires understanding, sensitivity, and skill. The fears, doubts, questions, and emotional challenges encountered must be effectively dealt with in order for deep healing to take place. Medications can play an important role in the process, particularly on a short-term basis, under the guidance of a qualified physician. However, the majority of patients and family members who encounter emotional turbulence on their journey through cancer will benefit even more greatly from personal dialogues and one-on-one counseling with an experienced professional.

We all have the opportunity to live in a state of love and forgiveness, allowing the heart to be free, whole, and released from judgment, despair, and resentment. The goal of Level 4 is to address and facilitate this process as consciously, fully, and elegantly as possible.

Take action: see How You Can Accomplish Level 4 Today.

Subscribe to Seven Levels of Healing® eNewsletter

< Previous Level   7 Levels Overview Page   Next Level>

Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health